ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF

Abstract: provided are an anti-4-1bb/anti-her2 bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.

Inventor(s): Hyejin CHUNG, Yeryoung YONG, Kyeongsu PARK, Eunyoung PARK, Ui-Jung JUNG, Yangsoon LEE, Eunjung KIM, Yong-Gyu SON, Wonjun SON, Seawon AHN, Donghoon YEOM, Chanmoo LEE, Junghyeon HONG, Moo Young SONG, Eun-Jung LEE, Na Rae LEE, Young Bong PARK, Eun-Jung LEE, Taewang KIM

CPC Classification: C07K16/32 (PEPTIDES (peptides in foodstuffs ; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs ; preparations for medicinal purposes ; peptides containing beta-lactam rings ; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, ; ergot alkaloids of the cyclic peptide type ; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids ; macromolecular products derived from proteins ; preparation of glue or gelatine ; single cell proteins, enzymes ; genetic engineering processes for obtaining peptides ; compositions for measuring or testing processes involving enzymes ; investigation or analysis of biological material ))

Search for rejections for patent application number 20250163180